Infectious Disease Diagnostics Market - By Type: Molecular Diagnostics, Immunoassays, Microbial Culture, Others. By Pathogen: Bacteria, Viruses, Fungi, Others. By Application: Hospital Laboratories, Diagnostic Centers, Point of Care Testing. By Region: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa.
The Global Infectious Disease Diagnostics Market is experiencing unprecedented growth driven by emerging pathogens, increasing antimicrobial resistance, and technological advancements in diagnostic techniques. Valued at USD 28.4 billion in 2023, the market is projected to expand at a CAGR of 7.9%, reaching USD 51.2 billion by 2031.
The COVID-19 pandemic has fundamentally transformed the diagnostics landscape, accelerating the development and adoption of rapid testing platforms. Emerging threats such as antimicrobial-resistant infections and zoonotic diseases are further driving market growth. This report offers detailed segmentation analysis, regional insights, and future projections to assist stakeholders in navigating this evolving market.
2. Market Overview
2.1 Market Definition & Scope
Infectious disease diagnostics encompass technologies and products used to detect pathogens causing diseases in humans. The market includes:
2.2 Market Size & Forecast (2023-2031)
2.3 Key Market Segments
By Product Type:
By Technology:
By Disease Type:
By End User:
By Region:
3. Market Dynamics
3.1 Market Drivers
1. Pandemic Preparedness Initiatives
2. Antimicrobial Resistance Crisis
3. Technological Advancements
4. Point-of-Care Testing Expansion
3.2 Market Challenges
1. Regulatory Hurdles
2. Reimbursement Limitations
3. Supply Chain Vulnerabilities
3.3 Market Trends
1. Multiplex Testing Adoption
2. Digital Pathology Integration
3. Home Testing Expansion
4. Competitive Landscape
4.1 Market Share Analysis
|
Company |
Market Share |
Key Products |
Strategic Focus |
|
Roche Diagnostics |
22% |
cobas® systems |
Molecular diagnostics |
|
Abbott Laboratories |
18% |
ID NOW™ platform |
Point-of-care testing |
|
Thermo Fisher Scientific |
15% |
TaqPath™ assays |
High-throughput testing |
|
bioMérieux |
12% |
VITEK® systems |
Automated microbiology |
|
Danaher Corporation |
10% |
Cepheid GeneXpert |
Rapid molecular testing |
4.2 Emerging Players
4.3 Recent Developments (2024)
5. Regional Analysis
5.1 North America (XX%)
5.2 Europe (XX%)
5.3 Asia-Pacific (28%)
6. Future Outlook
6.1 Short-Term Projections (2025)
6.2 Medium-Term Outlook (2027)
6.3 Long-Term Forecast (2031)
Global Infectious Disease Diagnostics Market Report
Need help?
Chat with our team in a minute.